Stocks · Health care · Pharmaceutical Preparations

BridgeBio Pharma, Inc.

BBIO Clue Score39

United States Fiscal year ends December CIK 0001743881 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

By person

28 insiders · 457 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

KKR Genetic Disorder L.P.

10% owner

$45.00M (1)

$840.72M (5)

−$795.72M

13,260,971

6.78%

$966.06M

—

Viking Global Investors LP entity

10% owner

$80.00M (1)

$313.49M (3)

−$233.49M

18,555,375

9.49%

$1.35B

—

Neil Kumar

Chief Executive Officer

—

$149.49M (216) scheduled

−$149.49M

5,563,146

2.85%

$405.28M

—

Viking Global Performance LLC entity

10% owner

$80.00M (1)

—

+$80.00M

26,620,991

13.62%

$1.94B

—

Frank McCormick

Director

—

$33.91M (22) scheduled

−$33.91M

690,558

0.3532%

$50.31M

—

Jennifer E. Cook

Director

—

$21.92M (6) scheduled

−$21.92M

8,383

0.0043%

$610.70K

—

Charles J Homcy

Director

—

$19.45M (10) scheduled

−$19.45M

919,876

0.4706%

$67.01M

+11,522%

Andrew Lo

Director

$98.85K (2)

$10.17M (5)

−$10.07M

68,662

0.0351%

$5.00M

−72.1%

Brian C Stephenson

CFO and Treasurer

$1.44M (2)

$11.31M (47) scheduled

−$9.87M

102,464

0.0524%

$7.46M

+2,112%

Richard H Scheller

Director

—

$9.47M (8)

−$9.47M

53,822

0.0275%

$3.92M

—

Andrea Ellis

Director

$100.68K (1)

$7.87M (5) scheduled

−$7.77M

22,579

0.0116%

$1.64M

—

Thomas Trimarchi

President and CFO

—

$5.99M (9) scheduled

−$5.99M

336,529

0.1721%

$24.52M

−14.8%

Hannah Valantine

Director

$69.58K (3)

$5.58M (16) scheduled

−$5.51M

9,657

0.0049%

$703.51K

+1,132%

Ronald J Daniels

Director

$298.68K (2)

$4.04M (2) scheduled

−$3.74M

20,981

0.0107%

$1.53M

—

Michael Thomas Henderson

Chief Business Officer

$119.00K (1)

$3.75M (35) scheduled

−$3.64M

274,211

0.1403%

$19.98M

+17,299%

Cameron Turtle

See Remarks

—

$3.63M (17) scheduled

−$3.63M

12,568

0.0064%

$915.58K

—

Randal W. Scott

Director

$1.00M (1)

$2.48M (17) scheduled

−$1.48M

15,589

0.0080%

$1.14M

+211.8%

James C Momtazee

Director

$1.16M (1)

—

+$1.16M

19,070

0.0098%

$1.39M

—

Maricel Apuli

Chief Accounting Officer

—

$852.35K (8) scheduled

−$852.35K

120,687

0.0617%

$8.79M

−3.8%

Fred Hassan

Director

$273.39K (1)

—

+$273.39K

29,879

0.0153%

$2.18M

—

Brent L Saunders

Director

$254.88K (1)

—

+$254.88K

17,600

0.0090%

$1.28M

—

Douglas A. Dachille

Director

$245.58K (3)

—

+$245.58K

30,579

0.0156%

$2.23M

—

Uma Sinha

Chief Scientific Officer

$238.00K (1)

—

+$238.00K

16,460

0.0084%

$1.20M

—

Ali J. Satvat

Director

—

—

—

169,983

0.0870%

$12.38M

—

Brian M. Stolz

Chief Operating Officer

—

—

—

24,615

0.0126%

$1.79M

+3,258%

Eric Aguiar

Director

—

—

—

10,579

0.0054%

$770.68K

—

Yi Ching Yau

Chief Accounting Officer

—

—

—

4,586

0.0023%

$334.09K

+525.6%

KKR Management Holdings L.P. entity

10% owner

—

—

—

0

0.0000%

$0.00

−100.0%